ICICI Bank (NYSE: IBN) CFO discloses extensive share and option holdings
Rhea-AI Filing Summary
ICICI Bank Ltd Group Chief Financial Officer Anindya Banerjee has filed an initial insider report detailing his existing equity and stock option holdings in the bank. The filing shows direct ownership of 450,038 Equity Shares of par value Rs. 2 per share.
In addition, he holds multiple tranches of stock options, each giving the right to apply for one Equity Share. These options cover various grants from 2015 through 2025, with exercise prices translated for convenience into U.S. dollars ranging from about 2.40 to 14.67 per share and individual grants including 96,600, 101,800, 101,200 and 214,225 underlying shares, among others.
The footnotes explain vesting schedules and expirations for each grant, and indicate that several older tranches have already been fully exercised. This filing records Banerjee’s current position as an officer of the company rather than new market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
12 transactions reported
Mixed
12 txns
Insider
Banerjee Anindya
Role
Group Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Equity Shares, par value Rs. 2 per share | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,257,932 shares (Direct);
Equity Shares, par value Rs. 2 per share — 450,038 shares (Direct)
Footnotes (13)
- F1. A total of 96,600 stock options granted on April 17, 2025 and vesting in three tranches: (i) 28,980 vesting on April 17, 2026 and expiring on April 16, 2031, (ii) 28,980 vesting on April 17, 2027 and expiring on April 16, 2032, and (iii) 38,640 vesting on April 17, 2028 and expiring on April 16, 2033.
- F2. Each stock option represents the contingent right to apply for one Equity Share.
- F3. The exercise prices of the stock options are denominated in Rupee and translated for convenience only into USD at the rate of INR92.47 to US$1.00, the exchange rate set forth int he H.10 statistical release of the Federal Reserve Board on March 13, 2026.
- F4. A total of 101,800 stock options granted on April 26, 2024 and vesting in three tranches: (i) 30,540 vested on April 26, 2025 and expiring on April 25, 2030, (ii) 30,540 vesting on April 26, 2026 and expiring on April 25, 2031, and (iii) 40,720 vesting on April 26, 2027 and expiring on April 25, 2032.
- F5. A total of 101,200 stock options granted on April 21, 2023 and vesting in three tranches: (i) 30,360 vested on April 21, 2024 and expiring on April 20, 2029, (ii) 30,360 vested on April 21, 2025 and expiring on April 20, 2030, and (iii) 40,480 vesting on April 21, 2026 and expiring on April 20, 2031.
- F6. A total of 89,200 stock options granted on April 23, 2022 and vesting in three tranches: (i) 26,760 vested on April 23, 2023 and expiring on April 22, 2028, (ii) 26,760 vested on April 23, 2024 and expiring on April 22, 2029, and (iii) 35,680 vested on April 23, 2025 and expiring on April 22, 2030.
- F7. A total of 90,600 stock options granted on April 24, 2021 and vesting in three tranches: (i) 27,180 vested on April 24, 2022 and expiring on April 23, 2027, (ii) 27,180 vested on April 24, 2023 and expiring on April 23, 2028, and (iii) 36,240 vested on April 24, 2024 and expiring on April 23, 2029.
- F8. A total of 140,500 stock options granted on May 9, 2020 and vesting in three tranches: (i) 42,150 vested on May 9, 2021 and expiring on May 8, 2026, which have been fully exercised by the Reporting Person prior to expiration, (ii) 42,150 vested on May 9, 2022 and expiring on May 8, 2027, and (iii) 56,200 vested on May 9, 2023 and expiring on May 8, 2028.
- F9. A total of 142,100 stock options granted on May 6, 2019 and vesting in three tranches: (i) 42,630 vested on May 6, 2020 and expired on May 5, 2025, which have been fully exercised by the Reporting Person prior to expiration, (ii) 42,630 vested on May 6, 2021 and expiring on May 5, 2026, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 56,840 vested on May 6, 2022 and expiring on May 5, 2027.
- F10. A total of 214,225 stock options granted on May 3, 2017 and vesting in three tranches: (i) 64,268 vested on May 3, 2018 and expiring on May 2, 2028, (ii) 64,267 vested on May 3, 2019 and expiring on May 2, 2029, and (iii) 85,690 vested on May 3, 2020 and expiring on May 2, 2030.
- F11. A total of 151,525 stock options granted on April 28, 2016 and vesting in three tranches: (i) 45,458 vested on April 28, 2017 and expiring on April 27, 2027, which have been fully exercised by the Reporting Person prior to expiration, (ii) 45,457 vested on April 28, 2018 and expiring on April 27, 2028, and (iii) 60,610 vested on April 28, 2019 and expiring on April 27, 2029.
- F12. A total of 239,250 stock options granted on September 16, 2015 and vesting in two tranches: (i) 119,625 vested on April 30, 2018 and expiring on April 29, 2028 and (ii) 119,625 vested on April 30, 2019 and expiring on April 29, 2029.
- F13. A total of 159,500 stock options granted on April 27, 2015 and vesting in three tranches: (i) 47,850 vested on April 27, 2016 and expiring on April 26, 2026, which have been fully exercised by the Reporting Person prior to expiration, (ii) 47,850 vested on April 27, 2017 and expiring on April 26, 2027, which have been fully exercised by the Reporting Person prior to expiration, and (iii) 63,800 vested on April 27, 2018 and expiring on April 26, 2028.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does ICICI Bank (IBN) Group CFO Anindya Banerjee report in this Form 3?
He reports his existing holdings in ICICI Bank, including 450,038 Equity Shares and multiple stock option grants. The options span grants from 2015 to 2025, each giving the right to apply for one Equity Share under defined vesting and expiration schedules.
What stock option grants are disclosed for ICICI Bank (IBN) Group CFO?
He discloses several stock option grants, including tranches of 96,600, 101,800, 101,200, 89,200 and 214,225 underlying shares. Each stock option represents a contingent right to apply for one Equity Share, subject to vesting and future expiration dates.
What are the exercise prices of the ICICI Bank (IBN) options held by the CFO?
The options have exercise prices denominated in Rupees, translated for convenience into U.S. dollars. The reported translated exercise prices range from about US 2.40 to 14.67 per share, depending on the individual grant and its terms.
Does the ICICI Bank (IBN) Form 3 show any insider buying or selling?
No new market purchases or sales are indicated. The entries are classified as holdings, with footnotes describing grant dates, vesting and exercises already completed. The report primarily establishes the Group CFO’s existing equity and option position with the company.
Have any of the ICICI Bank (IBN) stock options already been exercised by the CFO?
Yes, several older tranches are stated as fully exercised prior to expiration, including portions of grants from 2015, 2016, 2019 and 2020. The remaining tranches continue to vest or remain outstanding with future expiration dates as described in the footnotes.